Home⇛Health Sciences Journal⇛vol. 11 no. 1 (2022)

Risk factors of PTSD, depression and anxiety in patients with previous COVID-19 infection: A systematic review and meta-analysis

Ira Maria Ma M. Aquino | Regina Ira Antonette M. Geli | Lindsley L. Go | Jose Ronilo G. Juangco

 

Abstract:

Introduction Studies showed that those who tested positive for COVID-19 have a 65% risk for a psychiatric disorder, while those undergoing isolation or quarantine are put at risk for anxiety and depression. The objective of this study was to appraise studies that determine the risk factors for psychiatric disorder post-COVID-19 infection. Methods All cross-sectional and cohort studies from 2019 onwards that had COVID-19 survivors that developed anxiety, depression and/or post-traumatic stress disorder (PTSD), were included. Medline, Cochrane Library and ClinicalKey were searched using MeSH terms including “COVID-19”, “depression”, “anxiety”, “post-traumatic stress disorder”, and “risk factor”. The risk of bias was assessed using the Newcastle-Ottawa scale. The data extracted from the studies were characteristics of the participants, risk factors, outcome measures and outcomes. Results Four cohort and four cross-sectional studies involving 1438 COVID-19 survivors who developed depression, anxiety and/or depression were included. The risk factors that were statistically significant were 1) female sex (RR = 1.86; 95% CI 1.06, 2.04; Z = 2.32; p = 0.02) for depression, 2) having family members infected with COVID-19 (RR = 1.56; 95% CI 1.32, 1.85; Z= 5.17; p = <0.01) for depression, 3) steroid administration during hospital admission (RR = 1.62; 95% CI 1.07, 2.47; Z = 2.26; p = 0.02) for anxiety and 4) female sex (RR = 2.13; 95% CI 1.16, 3.91; Z = 2.45, p = 0.01) for PTSD. Conclusion Female sex increases the risk of depression and PTSD. A family history of COVID-19 increases the risk of depression. Steroid administration is a risk factor for anxiety.



References:

  1. Mazza M, De Lorenzo R, Conte C, et al. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav Immun [Internet]. 2020; 89: 594-600. doi: 10.1016/j.bbi.2020.07.037
  2. Shmerling R. Do vitamin D, zinc, and other supplements help prevent COVID-19 or hasten healing? [Internet]. Harvard Health Publishing; 2021 April [cited 2021 September 4] Available from https://www.health.harvard.edu/blog/do-vitamin-d-zinc-and-other-supplements-help-prevent-covid-19-or-hasten-healing-2021040522310
  3. Reinburg S. Half of COVID survivors struggle with depression. HealthDay [Internet]. 2021 Mar 16 [cited 2021 Sep 4]. Available from https://www.healthline.com/health-news/people-with-covid-19-more-likely-to-develop-depression-anxiety-and-dementia#COVID-19-patients-risk-for-first-time-diagnosis-is-doubled
  4. Ma YF, Li W, Deng HB, et al. Prevalence of depression and its association with quality of life in clinically stable patients with COVID-19. J Affect Disord [Internet]. 2020 Oct 1; 275: 145-8.
  5. Wu C, Hu X, Song J, et al. Mental health status and related influencing factors of COVID-19 survivors in Wuhan, China. Clin Transl Med [Internet]. 2020 Jun;10(2): e52.
  6. PRISMA Checklist http://prisma-statement.org/PRISMAStatement/Checklist.aspx
  7. Cochrane Handbook for Systematic Reviews of Prognosis Studies online. https://training.cochrane.org/online-learning/cochrane-methodology/systematic-review-prognosis-studies
  8. Cochrane Handbook: Identifying and measuring h e t e r o ge n e i t y. h t t p s : / / h a n d b o o k - 5 - 1 . c o c h r a n e.org/chapter_9/9_5_2_identifying_and_measuring_heterogeneity.htm
  9. Beck K, Vincent A, Becker C, Keller A, Cam H. Prevalence and factors associated with psychological burden in COVID-19 patients and their relatives: A prospective observational cohort study. PLOS ONE [Internet]. 2021; 16(5): e0250590. doi.org/10.1371/journal. pone.0250590
  10. Benzakour L, Braillard O, Mazzola V, et al. Impact of peritraumatic dissociation in hospitalized patients with COVID-19 pneumonia: A longitudinal study. J Psychiatr Res [Internet]. 2021; 140 (2021): 53–9. doi.org/10.1016/j.jpsychires.2021.05.031
  11. Cai X, Hu X, Ekumi IO, Wang J, An Y, Li Z, Yuan B. Psychological distress and its correlates among COVID-19 survivors during early convalescence across age groups. Am J Geriatr Psychiatr [Internet]. 2020 Oct; 28(10): 1030-9. doi: 10.1016/j.jagp.2020.07.003
  12. Ju Y, Liu J, Ng RMK, et al. Prevalence and predictors of post-traumatic stress disorder in patients with cured coronavirus disease 2019 (COVID-19) one month post-discharge. Eur J Psychotraumatol [Internet]. 2021 Jun 17; 12(1): 1915576. doi: 10.1080/20008198.2021.1915576
  13. Chang M, Park D. Incidence of post-traumatic stress disorder after coronavirus disease. Healthcare [Internet]. 2020; 8: 373; doi:10.3390/healthcare8040373
  14. Imran J, Nasa P, Alexander L, Upadhyay S, Alanduru V. Psychological distress among survivors of moderate-to-critical COVID-19 illness: A multicentric prospective cross-sectional study. Indian J Psychiatry [Internet]. 2021 May-Jun; 63(3): 285-9. doi: 10.4103/psychiatry. IndianJPsychiatry_1074_20
  15. Liu D, Baumeister RF, Veilleux JC, Chen C, Liu W, Yue Y, Zhang S. Risk factors associated with mental illness in hospital discharged patients infected with COVID-19 in Wuhan, China. Psychiatr Res [Internet]. 2020 Oct; 292: 113297. doi: 10.1016/j.psychres.2020.113297.
  16. Xu F, Wang X, Yang Y, et al. Depression and insomnia in COVID-19 survivors: A cross-sectional survey from Chinese rehabilitation centers in Anhui province. Sleep Med [Internet]. 2021 Feb 8: S1389-9457(21)00093-9. doi: 10.1016/j.sleep.2021.02.002. Epub ahead of print.
  17. Lee CH, Giuliani F. The role of inflammation in depression and fatigue. Front Immunol [Internet]. 2019 Jul 19; 10:1696. doi: 10.3389/fimmu.2019.01696
  18. Lilly MM, Pole N, Best SR, Metzler T, Marmar CR. Gender and PTSD: What can we learn from female police officers? J Anxiety Disord [Internet]. 2009 Aug; 23(6): 767-74. doi: 10.1016/j.janxdis.2009.02.015. Epub 2009 Mar 11.
  19. Koçak O, Koçak ÖE, Younis MZ. The psychological consequences of COVID-19 fear and the moderator effects of individuals’ underlying illness and witnessing infected friends and family. Int J Environ Res Public Health [Internet]. 2021 Feb 13; 18(4): 1836. doi: 10.3390/ijerph18041836
  20. Grover S, Sahoo S, Rijal R, Mehra A. Don’t forget me in amidst of COVID-19 pandemic: A case series and review of literature on steroid associated psychiatric manifestations. Brain Behav Immun Health [Internet]. 2021 Sep 15: 100345. doi: 10.1016/j.bbih.2021.100345

Tools


Copyright © 2024  KITE Digital Educational Solutions |  Exclusively distributed by CE-Logic